Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 13, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • VACCINE
  • Page 6

Tag: VACCINE

  • BiotechToday
  • World

Cancer Vaccines: A Concoction Strategy to fight Leukemia

bioxone October 15, 2020October 15, 2020

Chitra Roy, University of Calcutta Leukemia is a malignancy of blood cells that starts to develop when the DNA of a single cell in the bone marrow mutates and fails to develop and function properly. These leukemia cells crowd out normal blood cells, making it difficult for the normal cells to do their job. Chronic […]

Read More
  • BiotechToday
  • World

Factor D: Can blocking immune system pathway stop COVID-19?

bioxone October 13, 2020October 13, 2020 3

Husna, Amity University Kolkata As the world is waiting anxiously for a powerful and effective vaccine against covid-19, researchers are also trying to identify how coronavirus attacks the body to stop its devastating impact. One such possible way has been discovered in a recent study by researchers of John Hopkins University. This can be done […]

Read More
  • BiotechToday
  • India
  • World

AstraZeneca: Late-stage trial of Covid-19 antibody medicine to start soon

bioxone October 12, 2020October 12, 2020

Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]

Read More
  • BiotechToday
  • India
  • World

COVID-19 or flu? Which one to control first?

bioxone October 7, 2020October 7, 2020

Camelia Bhattacharyya, Amity University Kolkata Amidst the pandemic prevailing recently due to the SARS-CoV-2, there is something which still can’t be ignored, the flu which leads to thousands of deaths in the US and infects about 11% of the population each year according to CDC. With the arrival of the flu along with the COVID-19, […]

Read More
  • BiotechToday
  • India
  • World

Here’s how COVID-19 vaccine BNT162b1 produces human antibody and helper T-cell responses

bioxone October 4, 2020October 4, 2020

Ayooshi Mitra, Amity University Kolkata To avert the spread of the pandemic of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a successful vaccine is needed. In an examination directed recently, safety, tolerability, and neutralizer reaction information from an on-going placebo-controlled treatment observer-blinded phase 1/2 coronavirus disease 2019 (COVID-19) vaccine trial BNT162b1, a lipid nanoparticle (LNP) nucleoside-modified […]

Read More
  • BiotechToday
  • India

Big breakthrough! ICMR and BIOLOGICAL E LTD develop a potential treatment for Covid-19

bioxone October 2, 2020October 2, 2020 1

-Aishila Kar, Amity University Kolkata The Indian Council of Medical Research (ICMR) in partnership with Hyderabad-based vaccine maker Biological E, has developed a “highly purified antisera” which will be utilized in the prevention and treatment of Covid-19. Antisera are blood sera that carry antibodies against a selected viral toxin or antigen and are introduced to […]

Read More
  • BiotechToday
  • India
  • World

mRNA-1273: A COVID vaccine for the old?

bioxone October 1, 2020October 1, 2020

Prama Ghosh, Amity University Kolkata Severity and death from Coronavirus disease 2019 (Covid-19) are associated with the older population; testing such vaccine candidates is important to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A phase 1, open-label trial with an escalated dose of messenger RNA vaccine, mRNA-1273, which encodes the stabilized prefusion […]

Read More
  • World

Widespread Bacterial disease in China renders Men Infertile

bioxone September 19, 2020September 19, 2020

Sayak Banerjee, Amity University Kolkata The Chinese authorities attested that a various number of people in northwest China have tested positive for brucellosis, a bacterial disease which is supposedly infected through livestock carrying the bacteria Brucella, due to an outbreak that generated from a leak at a biopharmaceutical factory in the previous year. The factory […]

Read More
  • BiotechToday
  • World

JAGN1: A new soldier in the immune system

bioxone September 17, 2020September 17, 2020

–PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA The foundation for the quest in vaccine discovery lies in antibodies and its immune response. Immunoglobulins (minute proteins) are the sole defenders against invading pathogens. Therefore, the detailed study of the immune system is a fascination around the globe. Recently, Dr. Josef Penninger’s group at IMBA and UBC were amazed […]

Read More
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials to be resumed again

bioxone September 12, 2020September 12, 2020

-Anuska Sen, Team bioXone On 10th September 2020, that is 2 days back, Team BioXone had covered a piece of news stating the pause of the Covid-19 vaccine of AstraZeneca by Serum Institute. Today, it has been reported that once again, the trials for AstraZeneca’s Covid-19 vaccine has been successfully resumed. The one reason that […]

Read More

Posts navigation

1 2 3 4 5 6 7

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy